Bruce Levine, Ph.D. 🇺🇦

@bllphd.bsky.social

🧬🧪Professor @Pennmedicine #CellTherapy #Genetherapy #Inventor #Kymriah #CARTCell @TmunityTx & @CapstanTx CoFounder, Past President @ISCTGlobal @PNASNexus AE https://orcid.org/0000-0001-6971-8465

We’ve built an integrated platform designed to move programs from discovery into first-in-human studies with rigor, speed, and quality. What differentiates this model is not a single capability, but the integration: • Manufacturing • Process development • QC analytics and correlative science

What the peptide craze reveals about Americans’ relationship with risk. Great piece from @sarah-todd.bsky.social www.statnews.com/2026/04/06/r... It's so odd how many people will not trust proven biomedical approaches but embrace and literally shoot up with unproven things like peptides

What the peptide craze reveals about Americans’ relationship with risk

Why do RFK Jr. and other health influencers embrace unproven peptides while calling for more research into well-studied vaccines?

statnews.com

🚨Coming soon! Multiplex engineering using microRNA-mediated gene silencing in CAR T cells. In a single lentiviral vector- multiplex silencing & expression of a CAR, better expansion & viability than gene editing by electroporation www.frontiersin.org/journals/imm...

Frontiers | Multiplex engineering using microRNA-mediated gene silencing in CAR T cells

Multiplex gene edited CAR T cell therapies face challenges, including potential oncogenic risks from double-strand breaks. Targeted microRNAs (miRNAs) may of...

frontiersin.org

From Pink Sheet on continued departures from FDA’s biologics division and challenges backfilling openings. FDA biologics center reported 106 departures from Jan. 1 to June 30. These numbers don’t include the 100-150 who were part of the reduction-in-force insights.citeline.com/pink-sheet/a...

US FDA’s Biologics Center Departures Grew Before More Than 100 RIFs Exited

The Center for Biologics Evaluation and Research saw departures far outnumber new hires in the second and third quarters of FY 2025, before more than 100 people left July 14 after the reduction-in-for...

insights.citeline.com